Coronet Ventures invests in early-stage healthtech, medtech and biotech startups with the potential to scale to the U.S. market. Beyond capital, we offer access to Cedars-Sinai’s clinical ecosystem, validation infrastructure, and go-to-market support, helping entrepreneurs bridge the gap between innovation and global impact.

Before joining Coronet Ventures, Koen worked at Invest‑NL, the Dutch national impact investor, where he supported innovative life sciences ventures through investments. He holds a master’s degree in Regenerative Medicine & Technology and conducted advanced research at Harvard University’s Wyss Institute on vascularized kidney models.

He is passionate about connecting the Dutch and American healthcare ecosystems and supporting founders through clinical validation, early commercial traction, and long-term partnership.